• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PTX 4.65% 4.1¢

PRESCIENT THERAPEUTICS LIMITED

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is engaged in the development of personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 is a compound with the ability to block a cancer growth enzyme, geranylgeranyl transferase-1 (GGT-1). PTX-100 is in Phase Ib expansion cohort study in T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. PTX-200 is in Phase Ib/II trial in relapsed and refractory AML. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M is a platform for enhancing cell therapies by producing cells with superior phenotypes. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PTX
Daily happenings?.
6 7 8
11/05/24 478 211K
11/05/24 Last post  Marfox Comments Created with Sketch.  478  Views Created with Sketch.  211K 
PTX
PTX Media related
25 26 27
10/05/24 1.5K 632K
10/05/24 Last post  DerrickJ Comments Created with Sketch.  1.5K  Views Created with Sketch.  632K 
PTX
updated chart
53 54 55
10/05/24 3.2K 1.1M
10/05/24 Last post  duncrazor Comments Created with Sketch.  3.2K  Views Created with Sketch.  1.1M 
PTX 10/05/24 25 9.6K
10/05/24 Last post  Praetorian2011 Comments Created with Sketch.  25  Views Created with Sketch.  9.6K 
PTX 22/04/24 15 9.1K
22/04/24 Last post  Shellbell Comments Created with Sketch.  15  Views Created with Sketch.  9.1K 
PTX
Live Investor Briefing - today
16/04/24 27 11K
16/04/24 Last post  dalts66 Comments Created with Sketch.  27  Views Created with Sketch.  11K 
PTX
Blocking agent
06/04/24 11 4.8K
06/04/24 Last post  Shellbell Comments Created with Sketch.  11  Views Created with Sketch.  4.8K 
PTX 05/04/24 0 512
05/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  512 

See All Discussions arrow Created with Sketch.

Timeline

March 2024 Quarterly Update and Appendix 4C
30 Apr 09:57
 
PTX100 Ph1b results to be presented at specialist congress
08 Apr 12:39
 
Notification of cessation of securities - PTX
05 Apr 12:55
 
Appendix 4D and Half Year Financial Report
23 Feb 10:14
 
December 2023 Quarterly Update and Appendix 4C
31 Jan 11:52
 
PTX-100 Spotlight Presentation
18 Dec 10:53
 
View More arrow Created with Sketch.
(20min delay)
Last
4.1¢
Change
-0.002(4.65%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.3¢ 4.3¢ 4.0¢ $31.43K 775.2K

Buyers (Bids)

No. Vol. Price($)
1 13923 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 130000 2
View Market Depth
Last trade - 15.43pm 10/05/2024 (20 minute delay) ?
Last
4.0¢
  Change
-0.002 ( 2.44 %)
Open High Low Volume
4.2¢ 4.2¢ 4.0¢ 286775
Last updated 12.33pm 10/05/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.